A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm

Leukemia and Lymphoma

Volumn 50, Issue 6, 2009, Pages 932-936

  Au, Wing Y ^a   Wong, Kai Y ^a   Wan, Thomas S ^a   So, Jason C ^a   Srivastava, Gopesh ^a   Liang, Raymond ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

CD4 CD56; Masquerade; Plasmacytoid dendritic cell tumor

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN HEAVY CHAIN; LEUKOSIALIN; OCTAMER TRANSCRIPTION FACTOR 2; PREDNISOLONE; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE;

AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER RELAPSE; CASE REPORT; DENDRITIC CELL SARCOMA; FATALITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; PLASMACYTOID DENDRITIC CELL TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED, 80 AND OVER; ANTIGENS, CD20; ANTIGENS, CD4; ANTIGENS, CD56; BASE SEQUENCE; DENDRITIC CELLS; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; KARYOTYPING; LYMPHOMA, B-CELL; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-2; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 68449101744     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902878463     Document Type: Article

References (19)

1. Facchetti F, JonesDM, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, CampoE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors: Tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 145-147.
2. Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G, et al. CD4+CD56+hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol 2005; 36:1020-1024.
3. Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, et al. Clinical and biologic features of CD4(+) CD56(+) malignancies. Blood 2002;99:1556-1563.
4. Reichard KK, Burks EJ, Foucar MK, Wilson CS, Viswanatha DS, Hozier JC, et al. CD4(+) CD56(+) lineagenegative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol 2005;29:1274-1283.
5. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+hematodermic neoplasms): A review. Am J Clin Pathol 2005;123:662-675.
6. Suzuki R, Nakamura S, Suzumiya J, Ichimura K, Ichikawa M, Ogata K, et al. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): Prognostication and categorization according to anatomic sites of involvement. Cancer 2005;104:1022-1031.
7. Gibson SE, Dong HY, Advani AS, Hsi ED. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: Associations with B-cell antigen expression and myelomonocytic maturation. Am J Clin Pathol 2006;126:916-924.
8. Benhattar J, Delacretaz F, Martin P, Chaubert P, Costa J. Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms. Diagn Mol Pathol 1995;4:108-112.
9. Au WY, Srivastava G, Wong KY, Chung LP, Ma SK, Wan TS, et al. Transformation of diffuse large B-cell lymphoma into pre-B acute lymphoblastic leukemia: Clinicopathologic features and clonal relationship. Hum Pathol 2004;35:900-903.
10. Evans PA, Pott C, Groenen PJ, Salles G, Davi F, Berger F, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 concerted action BHM4-CT98-3936. Leukemia 2007;21:207-214.
11. Harris NL, Bhan AK. Distribution of T-cell subsets in follicular and diffuse lymphomas of B-cell type. Am J Pathol 1983;113:172-180.
12. Au WY, Wong KY, Wan TSK, So JC, Srivastava G, Wong SHM. Very late relapse of B cell lymphoma masquerading as blastic transformation of chronic myeloid leukemia. Leuk Lymphoma 2007;48:1414-1416.
13. Neumann M, Fries H, Scheicher C, Keikavoussi P, Kolb-Maurer A, Brocker E, et al. Differential expression of Rel/NF-kB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000;95:277-285.
14. Liu XY, Atkins RC, Feusner JH, Rowland JM. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement. Am J Hematol 2004;75:251-253.
15. Theriault C, Galoin S, Valmary S, Selves J, Lamant L, Roda D, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-g chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol 2000;13:1269-1279.
16. Leung R, Chow EE, Au WY, Chow C, Kwong YL, Lin SY, et al. CD4+/ CD56+hematologic malignancy with rearranged MLL gene. Hum Pathol 2006;37:247-249.
17. Foon KA, Thiruvengadam R, Saven A, Bernstein ZP, Gale RP. Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med 1993;119:63-73.
18. Pistoia V, Roncella S, Di Celle PF, Sessarego M, Cutrona G, Cerruti G, et al. Emergence of a B-cell lymphoblastic lymphoma in a patient with B-cell chronic lymphocytic leukemia: Evidence for the single-cell origin of the two tumors. Blood 1991;78:797-804.
19. Wetzler M, Kurzrock R, Goodacre AM, McLaughlin P, Ku S, Talpaz M. Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic type. Cancer 1995;76:609-617.